CBD Found To Be A Safe And Effective Treatment For Multiple Sclerosis Symptoms

A new study has determined that CBD can be a safe and effective treatment for symptoms of multiple sclerosis.

A Phase 1 clinical trial recently published in the Journal of Clinical Pharmacology in Drug Development found that the oral CBD compound PTL101 – a new formulation of highly purified CBD in seamless gelatin matrix pellets – helped treat spasticity in those suffering from MS.

Researchers with Phytotech Therapeutics sought to determine how PTL101 is absorbed, distributed, and expelled throughout the body, as well as whether a 10 or 100 mg dose is more effective. They also compared the effects to Sativex, a CBD-based oromucosal spray approved for use in hospitals in Israel and Europe.

The trial took place in Israel and used GelpellR technology, which creates organic PTL101 beads.  

“PTL101 is a pharmaceutical-grade, user-friendly oral formulation that demonstrated safe and efficient delivery of CBD and therefore could be an attractive candidate for therapeutic indications,” reads the study.

Phase 2 of the study is expected to finish sometime in December.

h/t Pot Network

Latest.

As medical marijuana continues to gain ground across the US, more and more colleges are adding cannabis to their curriculum. In fact, more than half of America's pharmaceutical schools (62 percent) now teach students about medical marijuana according to a new survey conducted by researchers from the University of Pittsburgh's School of Pharmacy. "With more states legalizing medical marijuana, student pharmacists must be prepared to effectively care for their patients who may use medical marijuana alone or in combination with prescription or over-the-counter medications," the study's authors wrote.